Agency Forms Undergoing Paperwork; Reduction Act Review, 38837 [E7-13730]

Download as PDF 38837 Federal Register / Vol. 72, No. 135 / Monday, July 16, 2007 / Notices manuscript submitted to the Journal of Clinical Investigation entitled: ‘‘Akt1 promotes physiologic, but antagonizes pathologic, cardiac growth.’’ • Figures 3A, 3C, and 4A in: Welsh, C.F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M.A., & Assoian, R.K. ‘‘Timing of cyclin D1 expression within G1 phase is controlled by Rho.’’ Nature Cell Biology 3(11):950–957, 2001. • Figures 1, 2A, 2B, 3A, 3C, 4A, 4B, 6C, 6D, and 6E in: Roovers, K., & Assoian, R.K. ‘‘Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases.’’ Mol. Cell Biol. 23(12):4283–4294, 2003. Retracted in Mol. Cell Biol. 26(13):5203, July 2006. • Figures 1C, 2C, 5B, 5D, 6B and 6D in: Roovers, K., Klein, E.A., Castagnino, P., & Assoian, R.K. ‘‘Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression.’’ Developmental Cell 5 (2):273–284, 2003. Retracted in Developmental Cell 10(5):681, May 2006. Corrections were recommended by UP for the Nature Cell Biology paper. Dr. Roovers’ falsified Western blot data from the publications in Nature Cell Biology and from Developmental Cell were included in NIH grant applications CA 72639–07 and GM 69064–01. ORI has implemented the following administrative actions for a period of five (5) years, beginning on June 7, 2007: (1) Dr. Roovers is debarred from eligibility for any contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government referred to as ‘‘covered transactions’’ as defined in HHS’ implementation of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension at 2 CFR part 376, et seq.; and (2) Dr. Roovers is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E7–13703 Filed 7–13–07; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–07–06BM] Agency Forms Undergoing Paperwork; Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to: omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Notice of Correction Title of Project Randomized Controlled Trial of Routine Screening for Intimate Partner Violence—New—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Description of Correction A 30-day Federal Register Notice was published on June 25, 2007 (Vol. 72, No. 121, pp. 34691–34692) describing proposed activities with total estimated annualized burden of 717.7 hours. The annualized total burden hour estimate is correct, however, due to a clerical oversight, the table of Estimated Annualized Burden Hours contained non-annualized figures for the Number of Respondents (i.e., project totals). The corrected table appears below. The total estimated annualized burden hours are 717.7. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Women Seeking Health Care Services .......... Eligibility Script for Pretest ............................. Baseline Questionnaire for Pretest ................ Follow-up Questionnaire Pretest .................... Eligibility Script for Main Study ...................... Baseline Questionnaire for Main Study ......... Follow-up Questionnaire Main Study ............. 70 65 59 1,533 1,227 860 Number of responses per respondent Average burden per response (in hours) 1 1 1 1 1 1 1/60 15/60 12/60 1/60 17/60 22/60 DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P hsrobinson on PROD1PC76 with NOTICES Dated: July 9, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–13730 Filed 7–13–07; 8:45 am] Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under Project: National Evaluation of the Protection and Advocacy for Individuals with Mental Illness (PAIMI) Program—NEW In recognition that systematic evaluation of this and other government programs are part of good management VerDate Aug<31>2005 16:59 Jul 13, 2007 Jkt 211001 Substance Abuse and Mental Health Services Administration PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. E:\FR\FM\16JYN1.SGM 16JYN1

Agencies

[Federal Register Volume 72, Number 135 (Monday, July 16, 2007)]
[Notices]
[Page 38837]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13730]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-07-06BM]


Agency Forms Undergoing Paperwork; Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to: omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974.

Notice of Correction

Title of Project

    Randomized Controlled Trial of Routine Screening for Intimate 
Partner Violence--New--National Center for Injury Prevention and 
Control (NCIPC), Centers for Disease Control and Prevention (CDC).

Description of Correction

    A 30-day Federal Register Notice was published on June 25, 2007 
(Vol. 72, No. 121, pp. 34691-34692) describing proposed activities with 
total estimated annualized burden of 717.7 hours. The annualized total 
burden hour estimate is correct, however, due to a clerical oversight, 
the table of Estimated Annualized Burden Hours contained non-annualized 
figures for the Number of Respondents (i.e., project totals). The 
corrected table appears below. The total estimated annualized burden 
hours are 717.7.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden  per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Women Seeking Health Care Services....  Eligibility Script for                70               1            1/60
                                         Pretest.
                                        Baseline Questionnaire                65               1           15/60
                                         for Pretest.
                                        Follow-up Questionnaire               59               1           12/60
                                         Pretest.
                                        Eligibility Script for             1,533               1            1/60
                                         Main Study.
                                        Baseline Questionnaire             1,227               1           17/60
                                         for Main Study.
                                        Follow-up Questionnaire              860               1           22/60
                                         Main Study.
----------------------------------------------------------------------------------------------------------------


    Dated: July 9, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-13730 Filed 7-13-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.